AAAAAA

   
Results: 1-7 |
Results: 7

Authors: PRAHALADA S RHODES L GROSSMAN SJ HEGGAN D KEENAN KP CUKIERSKI MA HOE CM BERMAN C VANZWIETEN MJ
Citation: S. Prahalada et al., MORPHOLOGICAL AND HORMONAL CHANGES IN THE VENTRAL AND DORSOLATERAL PROSTATIC LOBES OF RATS TREATED WITH FINASTERIDE, A 5-ALPHA REDUCTASE INHIBITOR, The Prostate, 35(3), 1998, pp. 157-164

Authors: PRAHALADA S TARANTAL AF HARRIS GS ELLSWORTH KP CLARKE AP SKILES GL MACKENZIE KI KRUK LF ABLIN DS CUKIERSKI MA PETER CP VANZWIETEN MJ HENDRICKX AG
Citation: S. Prahalada et al., EFFECTS OF FINASTERIDE, A TYPE-2 5-ALPHA REDUCTASE INHIBITOR, ON FETAL DEVELOPMENT IN THE RHESUS-MONKEY (MACACA-MULATTA), Teratology, 55(2), 1997, pp. 119-131

Authors: RODRIGUEZ CG MAKORI N CUKIERSKI MA HENDRICKX AG
Citation: Cg. Rodriguez et al., DEVELOPMENT OF THE DEFINITIVE KIDNEY IN THE CYNOMOLGUS MONKEY (MACACA-FASCICULARIS), Journal of medical primatology, 25(2), 1996, pp. 122-132

Authors: MAKORI N RODRIGUEZ CG CUKIERSKI MA HENDRICKX AG
Citation: N. Makori et al., DEVELOPMENT OF THE BRAIN IN STAGED EMBRYOS OF THE LONG-TAILED MONKEY (MACACA-FASCICULARIS), Primates, 37(4), 1996, pp. 351-361

Authors: SPENCE SG ALLEN HL CUKIERSKI MA MANSON JM ROBERTSON RT EYDELLOTH RS
Citation: Sg. Spence et al., DEFINING THE SUSCEPTIBLE PERIOD OF DEVELOPMENTAL TOXICITY FOR THE AT(1)-SELECTIVE ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN IN RATS, Teratology, 51(6), 1995, pp. 367-382

Authors: SPENCE SG CUKIERSKI MA MANSON JM ROBERTSON RT EYDELLOTH RS
Citation: Sg. Spence et al., EVALUATION OF THE REPRODUCTIVE AND DEVELOPMENTAL TOXICITY OF THE AT(1)-SELECTIVE ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN IN RATS, Teratology, 51(6), 1995, pp. 383-397

Authors: PETTIBONE DJ CLINESCHMIDT BV GUIDOTTI MT LIS EV REISS DR WOYDEN CJ BOCK MG EVANS BE FREIDINGER RM HOBBS DW VEBER DF WILLIAMS PD CHIU SHL THOMPSON KL SCHORN TW SIEGL PKS KAUFMAN MJ CUKIERSKI MA HALUSKA GJ COOK MJ NOVY MJ
Citation: Dj. Pettibone et al., L-368,899, A POTENT ORALLY-ACTIVE OXYTOCIN ANTAGONIST FOR POTENTIAL USE IN PRETERM LABOR, Drug development research, 30(3), 1993, pp. 129-142
Risultati: 1-7 |